Ten COVID-19 vaccine candidates are now in Phase 3 clinical trials — the final leg of the process before their potential approval. But experts warn that final stamp won’t be an overnight solution.
This story was originally published on CBC News. To read the rest of this news worthy story, please visit https://www.cbc.ca/news/canada/toronto/covid19-vaccine-priorities-1.5769972?cmp=rss.